Oyster Point Pharma Inc (OYST) to be Acquired by Viatris (VTRS) for $11 Per Share Plus CVR streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MILWAUKEE, Nov. 7, 2022 /PRNewswire/ Ademi LLP is investigating Oyster Point Pharma for possible breaches of fiduciary duty and other violations of law in its transaction with Viatris. .